Submitted by Anonymous (not verified) on 19 February 2026 - 15:30
Human medicines European public assessment report (EPAR): Lynparza, olaparib, Date of authorisation: 16/12/2014, Revision: 31, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Lynparza, olaparib, Date of authorisation: 16/12/2014, Revision: 31, Status: Authorised